Targeted therapies for chronic myeloid leukemia and cardiovascular system

Journal Title: OncoReview - Year 2013, Vol 3, Issue 3

Abstract

Morbidity of chronic myeloid leukemia is recorded in elderly population, in patients with coexisting significant risk factors for atherosclerosis and heart diseases. Molecularly targeted therapy, imatinib, dasatinib and nilotinib, improve significantly the prognosis. However, the similar molecular targets in the form of different kinases are essential for cardiovascular system and blocking their pathways may have adverse effects. There is evidence about risk of systolic heart failure related to imatinib, pulmonary arterial hypertension induced by dasatinib and ischemic events associated with peripheral arterial disease and observed during nilotinib therapy. Some groups of patients with defined risk factors need appropriate cardiac monitoring.

Authors and Affiliations

Sebastian Szmit, Wiesław Jędrzejczak, Adam Torbicki

Keywords

Related Articles

Zastosowanie echokardiografii w onkologii – uwagi praktyczne

Artykuł przedstawia współczesne zastosowanie echokardiografii w wykrywaniu pierwotnych i przerzutowych nowotworów serca oraz w ocenie ryzyka sercowo-naczyniowego związanego z farmakologicznym i zabiegowym leczeniem nowot...

Nuclear medicine diagnostic tools for early detection of myocardial damage in treated breast cancer patients

The most severe side effect in treated patients with breast cancer is treatment-induced cardiotoxicity, leading to chronic heart failure or CAD, and worsening the patient’s quality of life. The early detection and medica...

Tumor lysis syndrome

Tumor lysis syndrome is a life-threatening oncological emergency occurring in response to chemotherapy or spontaneously as a result of massive and rapid breakdown of malignant cells. The release of their contents into ci...

Skin of sailor: cutis rhomboidalis nuchae, actinic keratosis, squamous cell carcinoma and basal cell carcinoma. Case report

Chronic exposure to environmental ultraviolet radiation (UVR) plays a key role both in photocarcinogenesis and induction of accelerated skin ageing. Sailors commonly experience a significant number of cutaneous problems,...

Download PDF file
  • EP ID EP67722
  • DOI -
  • Views 254
  • Downloads 0

How To Cite

Sebastian Szmit, Wiesław Jędrzejczak, Adam Torbicki (2013). Targeted therapies for chronic myeloid leukemia and cardiovascular system. OncoReview, 3(3), 163-176. https://www.europub.co.uk/articles/-A-67722